XML 35 R23.htm IDEA: XBRL DOCUMENT v3.24.3
Equity
 9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Equity Equity
Accumulated other comprehensive income (loss)
Summarized below is the roll forward of accumulated other comprehensive income (loss), net of tax.
(in Millions)Foreign currency adjustments
Derivative Instruments (1)
Pension and other postretirement benefits
Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2023$(131.3)$(50.2)$(225.0)$(406.5)
2024 Activity
Other comprehensive income (loss) before reclassifications8.0 10.9 (0.2)18.7 
Amounts reclassified from accumulated other comprehensive income (loss)— 6.6 7.8 14.4 
Net current period other comprehensive income (loss)$8.0 $17.5 $7.6 $33.1 
Accumulated other comprehensive income (loss), net of tax at September 30, 2024$(123.3)$(32.7)$(217.4)$(373.4)

(in Millions)Foreign currency adjustments
Derivative Instruments (1)
Pension and other postretirement benefits
Total
Accumulated other comprehensive income (loss), net of tax at December 31, 2022$(160.5)$(51.7)$(247.4)$(459.6)
2023 Activity
Other comprehensive income (loss) before reclassifications (32.3)(55.2)— (87.5)
Amounts reclassified from accumulated other comprehensive income (loss)— 44.4 8.2 52.6 
Net current period other comprehensive income (loss)$(32.3)$(10.8)$8.2 $(34.9)
Accumulated other comprehensive income (loss), net of tax at September 30, 2023$(192.8)$(62.5)$(239.2)$(494.5)
____________________
(1)    See Note 17 for more information.
Reclassifications of accumulated other comprehensive income (loss)
The table below provides details about the reclassifications from accumulated other comprehensive income (loss) and the affected line items in the consolidated statements of income (loss) for each of the periods presented:
Details about Accumulated Other Comprehensive Income Components
Amounts Reclassified from Accumulated Other Comprehensive Income (Loss) (1)
Affected Line Item in the Consolidated Statements of Income (Loss)
Three Months Ended September 30,Nine Months Ended September 30,
(in Millions)2024202320242023
Derivative instruments
Gain (loss) on foreign currency contracts$(7.4)$(33.4)$(8.4)$(64.8)Costs of sales and services
Gain (loss) on foreign currency contracts(0.1)1.7 0.1 4.3 Selling, general and administrative expenses
Gain (loss) on interest rate contracts(0.5)(0.4)(1.5)(2.2)Interest expense, net
Total before tax$(8.0)$(32.1)$(9.8)$(62.7)
2.5 9.5 3.2 18.3 Provision (benefit) for income taxes
Amount included in net income (loss)$(5.5)$(22.6)$(6.6)$(44.4)
Pension and other postretirement benefits (2)
Amortization of unrecognized net actuarial and other gains (losses)(3.2)(3.2)(9.5)(10.4)Non-operating pension and postretirement charges (income)
Recognized (gain) loss due to curtailments, settlements, and other(0.1)— (0.3)— Non-operating pension and postretirement charges (income)
Total before tax$(3.3)$(3.2)$(9.8)$(10.4)
0.7 0.7 2.0 2.2 Provision (benefit) for income taxes; Discontinued operations, net of income taxes
Amount included in net income (loss)$(2.6)$(2.5)$(7.8)$(8.2)
Total reclassifications for the period$(8.1)$(25.1)$(14.4)$(52.6)Amount included in net income

____________________
(1)Amounts in parentheses indicate charges to the consolidated statements of income (loss).
(2)Pension and other postretirement benefits amounts include the impact from both continuing and discontinued operations. For detail on the continuing operations components of pension and other postretirement benefits, see Note 15.
Dividends and Share Repurchases
During each of the nine months ended September 30, 2024 and September 30, 2023, we paid dividends of $217.9 million. On October 17, 2024, we paid dividends totaling $72.8 million to our shareholders of record as of September 30, 2024. This amount is included in "Accrued and other liabilities" on the consolidated balance sheet as of September 30, 2024.
In February 2022, the Board of Directors authorized the repurchase of up to $1 billion of the Company's common stock. In connection with an amendment to the Company's credit agreement in November 2023, the Company agreed that it will not repurchase shares until September 30, 2025, with the exception of share repurchases under our equity compensation plans. Therefore, there were no share repurchases under the publicly announced repurchase program during the nine months ended September 30, 2024. At September 30, 2024, $825 million remained unused under our Board-authorized repurchase program. This repurchase program does not include a specific timetable or price targets and may be suspended or terminated at any time. Shares may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market conditions and other factors. We also reacquire shares from time to time from employees in connection with the vesting, exercise and forfeiture of awards under our equity compensation plans. Share repurchases in excess of issuances are subject to a 1 percent excise tax imposed by the 2022 Inflation Reduction Act. This tax is included as part of the cost basis of the shares acquired.